1. Home
  2. AVD vs ACRV Comparison

AVD vs ACRV Comparison

Compare AVD & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Vanguard Corporation ($0.10 Par Value)

AVD

American Vanguard Corporation ($0.10 Par Value)

HOLD

Current Price

$2.44

Market Cap

72.4M

Sector

Industrials

ML Signal

HOLD

Logo Acrivon Therapeutics Inc.

ACRV

Acrivon Therapeutics Inc.

HOLD

Current Price

$1.73

Market Cap

68.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVD
ACRV
Founded
1969
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.4M
68.5M
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
AVD
ACRV
Price
$2.44
$1.73
Analyst Decision
Strong Buy
Buy
Analyst Count
1
4
Target Price
$12.00
$11.67
AVG Volume (30 Days)
147.1K
400.2K
Earning Date
03-16-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
61.11
15.13
EPS
N/A
N/A
Revenue
$515,114,000.00
N/A
Revenue This Year
$8.82
N/A
Revenue Next Year
N/A
$568.17
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.05
$1.20
52 Week High
$5.92
$3.56

Technical Indicators

Market Signals
Indicator
AVD
ACRV
Relative Strength Index (RSI) 48.88 51.98
Support Level $2.50 $1.58
Resistance Level $2.68 $2.20
Average True Range (ATR) 0.12 0.09
MACD 0.00 -0.00
Stochastic Oscillator 59.37 74.07

Price Performance

Historical Comparison
AVD
ACRV

About AVD American Vanguard Corporation ($0.10 Par Value)

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. The company is a manufacturer of specialty solutions that develops and markets safe synthetic, biological, and biorational products for agricultural, commercial, and consumer uses. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1; ACR-2316 a selective, dual WEE1/PKMYT1 inhibitor; and ACR-6840, a development candidate targeting CDK11. It has one reportable segment focused on the research and development of precision oncology therapies.

Share on Social Networks: